Chris Heminway, Exec-Chair at Time To ACT, explains why now is the right time for the Group to IPO. Watch the video here.
worth remembering AGL have partnerships with huge pharma companies. billion dollar companies like abbot ($191B), QIAGEN ($11B) and Philips( $39B) when they finally secure FDA approval this will open up a wide selection of revenue streams and along with these partnerships it will open up the doors to huge step ups in revenue and production for parsortix.
so even the short- med term looks good based on future sp on FDA news. if your willig to hold long term in several years you will no doubt see many many multiples of current sp.
it certainly feels within touching distance... i say touching distance but for the LTH's the fda is now within touching distance (without any delays of course) april onwards isnt far away. i actually personally dont see it as soon as april and have a date mid may-june as these things always have a habit if running later than sooner but im more than happy to wake up to that red dot if its earlier than what i expect :)
volume will die off when the new comers get board that FDA approval hasnt came yet but im sure the next support will be 60p after we breach that level. i would imagine a bit of selling then and hopefully stabilise there before next big push feb-april time pre news.
all looking good whatever way you look at it. bottom potentially found... jupiter out or very close to being out... more investors buying giving support to current sp and its moving up. thumbs up from me
still no TR-1 for the new buyer! strange they got to be close to disclosing now. must be an USA ii. deep pockets whoever they are! be interesting to see over thr next few weeks. hoping jupiter to at least reveal they are under 3% before year end... even better get them out completely but id take the final rns for confirmation then its strap in for bouncy Mc bouncyface
managed to get a top up at 38.5p today. happy with that little add on since it had an intraday bounce right after it! im not too fussed where the bottom is to be honest like most on here im not looking too much into current sp and viewing to possobly trade in 6months anyway based on after FDA appoval sp. until then if it stays sub 45p i will continue to add.
nothing has changed for the company or no bad news has been released so you can only view the company as still on track for whatever theyve said they will aim for which they are, FDA approval in Q2 2021. jupiter is still keeping a lid on sp but fundamemtals havent changed so why should your investment view.
if its short term trading gains then yes that could effect your decision to hold or sell but most will know AGL is not a short term trading share unless lucky with next day RNS.
3% TR-1 RNS will be interesting. should bring some attention and signalling the near end of constant selling pressure. it will bounce hard and you'd usually miss it if your trying to be sweet and wait for the reversal. im happy enough with it just now. if others arent sell up at a loss and move on. plenty of high flyers out there in the aim market
the re-rate will come dibs ;) just need to build that position until it does which like researcher says wont be until jupiter is out. They have less than 10M shares, unkowm the exact number until next 3% is passed. AGL has been having some big volume days, compared to the daily volume of sub 300k before jupiters selling spree started, volume hasnt been sub 300k since before the start of november so theres still transfers happening between jupiter and the unknown ii(s). hence whem were stuck at this level, mm's will be happy to hold price in this level if buyer is happy to take them at 40-45p. you can see all the iceberg trades popping throughout the day 10k here 10k there... yet no movement to SP. mm's dont want to move price quickly up as the buyer might have a limit of say 45p when buying. if mms raise sp too much and scare off the buyer they will loose out on the trade dealing commissions. but its good to get jupiter out before the real movement happens... which might not really be until feb-march for people positioning up before the Q2 starts as FDA news could come along anytime april- june(even before if it goes quickly but im not holding my breathe)
since jupiter has sold near 7M(could be a lot more) then someone would of bought these and if its a single entity then that would make them a major shareholder going above the 3%. be nice to see whos been buying. maybe get knowledge of that next week.
so 17M down to below 10.7M. doesnt give detailed holding numbers left and dated back 18th, since then been having some big volume days so if it keeps going i expect a sub 3% RNS next week. 3% would be 6.4M. depending how big the buyers pockets are we could chomp through that in a couple weeks if volume keeps into the millions each day. get them out and wait for the re-rate/ bounce towards 60p :)
i dont think they sold, on the holdings RNS it sates it was ' an event changjng the breakdown of voting rights' ... instead of 'acquisition or disposal'.
their 5.76% holding was based on previous 172M shares before recent placing shares have came into play which now takes overall shares to 215M which would drop FIL ltd below 5%. its just them informing the market so still havent seen whos been dumping/transferring. my bets still jupiter but dont know whos been buying them. i expect a holding RNS in next couple of days/next week.
makes me think if this was already in play from the 60p range reasearch1, hence why the mm's have walked the sp down even on previous bullish news and FDA accectance along with the publishers reviews.
walked down until the 46p mark to be able to reduce jupiters holding and mms obv make their usual transaction fees between the two iis. and throw in the recent 46p placing price, its def a good area to stay at for the mms until both parties are happy to finish buying/selling. i really do hope the buyers have deep pockets and get jupiter out finally. 17M shares was still a fair chunk to get through but judging on recent volume there must be a good dent at it now.
dont know what threshold they will disclose at. will they wait until theyve reached 5% to disclose or will they disclose at a higher %. not sure.
i would say theres a transfer from one ii to another. ny guess is jupiters managed to offload to FIL limited or a new ii whos willing to buy at this range hence why these buy trades are contiously popping up without any movement in any direction on SP. what will be interesting is if jupiter are the ones selling when they sell out is the new buyer happy with those or are they still wanting more... wont actually know whos selling/buying until the tr-1's are published. and that will give a clue in how much jupiter still has to shift through (again in my opinion that its jupiter selling) be a good position for them to completely sell out prior FDA approval news. that would benefit us big time. without the constant selling pressure this will finally be able to move freely and rerate when the right news comes along. might have to wait a few months for that news but ill be happy to see that rise if it does ;)
doesnt seem enough volume to indicate a nice re-rate in sp. wonder if theres some chucky orders being worked into the background. 0.4p is cheap for the stock and looking at the charts its been well oversold and this area does bring in some strong support from previous bounces.